Russia to produce COVID-19 vaccine & launch millions of doses by 2021

Date: 2020-08-05   Author: Saipriya Iyer  Category: #news

Russia to produce COVID-19 vaccine & launch millions of doses by 2021

Russia has recently announced its target to start the mass production of a COVID-19 vaccine in September and increase the number to several million doses per month by 2021. The head of the fund which finances the clinical trials, Russian Direct Investment Fund, has revealed that the official registration of the vaccine is expected to be completed within 10 days. If achieved in 10 days, this COVID-19 vaccine will be the first to be registered across the globe, ahead of even the U.S. as well as other countries.

Sources familiar with the matter have stated that the country has been developing various vaccine prototypes. For instance, a vaccine candidate developed and studied by the Gamaleya research institute in Moscow is currently in the advanced stages of development and is likely to pass the state registration shortly. Sources further added that another vaccine, that is developed by Vektor lab based in Siberia, is presently undergoing the clinical trials, while 2 other vaccines will start the human trials in the next 2 months.

According to Denis Manturov, Russian Industry Minister, the country is anticipating the mass production of the vaccine in September and the development of the vaccine doses to several million by the beginning of 2021. He further added that a vaccine developer is currently preparing the production technology at 3 locations in Russia.

The viral vector vaccine developed by Gamaleya employs another virus that carries the DNA, which encodes the required immune response into the cells. Moreover, the adenovirus-based vaccine developed by Gamaleya is also in the advanced stage of clinical studies. Adenovirus is a similar technology to the COVID-19 vaccine prototype developed by CanSino in China.

Several months back, the Gamaleya institute was strongly criticized after its researchers and the director reportedly injected themselves with the vaccine prototype, which was regarded as a hasty and unorthodox decision. Moscow also has dismissed various allegations from the U.S., the UK, and Canada that a group of hackers linked with intelligence services in Russia had attempted to steal vaccine information from various labs in the West.

Source credit:

https://www.ndtv.com/world-news/coronavirus-russia-aims-to-produce-millions-of-vaccine-doses-by-2021-2273639



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Data Center Power Management Market Expected to Witness High Growth over the Forecast Period 2021 - 2026

Author: Ashwin Naphade

The ' Data Center Power Management market' study now available with Market Study Report, LLC, delivers a concise outlook of the powerful trends driving market growth. This report also includes valuable information pertaining to market share, marke...


Business Value Dashboard Market Outlook | Development Factors, Latest Opportunities and Forecast 2026

Author: Ashwin Naphade

The ' Business Value Dashboard market' study recently added by Market Study Report, LLC, offers an in-depth analysis of the current market trends influencing this business vertical. The study also includes market valuation, market size, revenue fo...


Global Cloud Based Backup Services Market - Detailed Analysis of Current Industry Figures with Forecasts Growth By 2026

Author: Ashwin Naphade

Market Study Report, LLC, provides a research on the ' Cloud Based Backup Services market' which offers a concise summary pertaining to industry valuation, SWOT Analysis, market size, revenue estimation and geographical outlook of the business ver...